홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Nicotinate

HCID 937
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

표준 SMILES
O=C([O-])c1cccnc1
InChIKey
PVNIIMVLHYAWGP-UHFFFAOYSA-M
분자식
C6H4NO2-
평균 분자량
122.1 g/mol
단동위원소 질량
122.02420337

개요

Nicotinate is a pyridinemonocarboxylate that is the conjugate base of nicotinic acid, arising from deprotonation of the carboxy group; major species at pH 7.3. It has a role as a metabolite and a Saccharomyces cerevisiae metabolite. It is a vitamin B3 and a pyridinemonocarboxylate. It is a conjugate base of a nicotinic acid.

이름 및 식별자

우선 이름
Nicotinate
IUPAC
pyridine-3-carboxylate

이름 및 동의어

nicotinate3-pyridinecarboxylateCHEBI:32544RefChem:927733pyridine-3-carboxylatenico-400-PVNIIMVLHYAWGP-UHFFFAOYSA-MAC-907/25004509AE-848/01496050Q27104221

데이터베이스 식별자

PubChem CID
937
ChEBI
CHEBI:32544
Nikkaji
J239.335B

물성

구조 계산 물성

XLogP
0.9
극성 표면적
53 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
0
무거운 원자 수
9
형식 전하
-1
복잡도
108

실험 및 물리화학적 성질

Collision Cross Section · 2건

121 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

124 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

TreatmentSupportive measures should be undertaken in the event of an overdose. (L1712)
Health Effects · 1건

Niacin at extremely high doses can have life-threatening acute toxic reactions. Extremely high doses of niacin can also cause niacin maculopathy, a thickening of the macula and retina which leads to blurred vision and blindness. This maculopathy is reversible after stopping niacin intake. Side effects of hyperglycemia, cardiac arrhythmias and birth defects have also been reported. (A729)

Exposure RoutesOral (L1436) ; Intramuscular (L1436). Both nicotinic acid and nicotinamide are efficiently absorbed from the stomach and small intestine.
Toxicity Summary · 1건

Niacin binds to Nicotinate D-ribonucleotide phyrophsopate phosphoribosyltransferase, Nicotinic acid phosphoribosyltransferase, Nicotinate N-methyltransferase and the Niacin receptor. Niacin is the precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital cofactors for dozens of enzymes. The mechanism by which niacin exerts its lipid lowering effects is not entirely understood, but may involve several actions, including a decrease in esterification of hepatic triglycerides. Niacin treatment also decreases the serum levels of apolipoprotein B-100 (apo B), the major protein component of the VLDL (very low-density lipoprotein) and LDL fractions.

Signs and Symptoms · 1건

Nicotinic acid can cause vasodilation of cutaneous blood vessels resulting in increased blood flow, principally in the face, neck and chest. This produces the niacin- or nicotinic acid-flush. The niacin-flush is thought to be mediated via the prostaglandin prostacyclin. Histamine may also play a role in the niacin-flush. Flushing is the adverse reaction first observed after intake of a large dose of nicotinic acid, and the most bothersome one.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Niacin is rapidly metabolized and undergoes extensive first-pass metabolism in the liver. The drug is converted to several metabolites, including nicotinuric acid (NUA), nicotinamide, and nicotinamide adenine dinucleotide (NAD). At doses used to treat hyperlipoproteinemia, the principal metabolic pathways appear to be saturable, and niacin is thought to exhibit nonlinear, dose-dependent pharmacokinetics. (L1323) Half Life: 20-45 minutes.

MeSH Pharmacological Classification · 3건

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.

Drugs used to cause dilation of the blood vessels.

A group of water-soluble vitamins, some of which are COENZYMES.

용도 및 제조

Uses · 1건

For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. It can be found in various foods, such as liver, chicken, beef, fish, cereal, peanuts and legumes. Niacin is also used as a pharmaceutical to reverse atherosclerosis. (A729)

관련 반응

13건
반응 기록 만들기
HRID 34899 반응식
HRID 34899반응물로
HRID 34900 반응식
HRID 34900반응물로
HRID 102188 반응식
HRID 102188생성물로
HRID 295972 반응식
HRID 295972생성물로
HRID 324688 반응식
HRID 324688생성물로
HRID 341516 반응식
HRID 341516반응물로
HRID 376482 반응식
HRID 376482반응물로
HRID 602234 반응식
HRID 602234반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Toxicity DataLD50: 7000 mg/kg (Oral, Rat) (T14) LD50: 730 mg/kg (Intraperitoneal, Rat) (T14) LD50: 3500 mg/kg (Subcutaneous, Mouse) (T14)